Marc Zapatka

28PUBLICATIONS
180CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.

Mario Hlevnjak, Sabine Heublein, Verena Thewes

|Oct 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.

Yu-Yu Lin, Kersten Breuer, Dieter Weichenhan

|Aug 07, 2025
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

L Llaó-Cid, Jkl Wong, I Fernandez Botana

|Jan 27, 2025
Author Correction: Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.

Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz

|Jan 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast

|Nov 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.

Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz

Pageof 5

Frequent Collaborators

8 joint publications

Peter Lichter

5 joint publications

Sascha Dietrich

5 joint publications

Martina Seiffert

5 joint publications

Matthias Schlesner